Back to Trades
Sell4
Heartflow, Inc.
HTFL
Total Value
$1.9M
Net $1.6M sold
Sales
$1.6M
1 transaction
Company Information
- Company Name
- Heartflow, Inc.
- Ticker Symbol
- HTFL
- CIK
- 0001464521
Insider Information
- Name
- Rogers Campbell
- Role
- Chief Medical Officer
- Location
- MOUNTAIN VIEW, CA
Officer
Filing Details
- Filing Date
- Apr 3, 2026
- Transaction Date
- Apr 1, 2026
- Accession Number
- 0001464521-26-000052
- Form Type
- 4
- Net Trading Amount
- -$1.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | 291 | $8.33 | Exercise | $2.4K |
| Apr 1, 2026 | Common Stock | 19,111 | $2.22 | Exercise | $42.4K |
| Apr 1, 2026 | Common Stock | 40,766 | $2.22 | Exercise | $90.5K |
| Apr 1, 2026 | Common Stock | 6,849 | $2.22 | Exercise | $15.2K |
| Apr 1, 2026 | Common Stock | 64,533 | $24.64 | Sale | $1.6M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 1, 2026 | Derivative | 6,849 | $2.22 | Exercise | $15.2K |
| Apr 1, 2026 | Derivative | 291 | $8.33 | Exercise | $2.4K |
| Apr 1, 2026 | Derivative | 19,111 | $2.22 | Exercise | $42.4K |
| Apr 1, 2026 | Derivative | 40,766 | $2.22 | Exercise | $90.5K |
Footnotes
- (F1)The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- (F2)The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- (F3)Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- (F4)This transaction was executed in multiple trades at price ranging from $24.03 to $25.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F5)These stock options are fully exercisable.
- (F6)The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.